Joensuu, H <br/><br/>
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  May 2010 
 - 968-73 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdp397  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Carcinoma, Ductal, Breast--drug therapy<br/>Carcinoma, Lobular--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Docetaxel<br/>Female<br/>Humans<br/>Immunoenzyme Techniques<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Neoplasm Metastasis<br/>Prospective Studies<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Survival Rate<br/>Taxoids--administration & dosage<br/>Treatment Outcome<br/>Gemcitabine